These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 22971864

  • 1. Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of Pityriasis rosea.
    Amatya A, Rajouria EA, Karn DK.
    Kathmandu Univ Med J (KUMJ); 2012; 10(37):57-61. PubMed ID: 22971864
    [Abstract] [Full Text] [Related]

  • 2. Use of high-dose acyclovir in pityriasis rosea.
    Drago F, Vecchio F, Rebora A.
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis.
    Rodriguez-Zuniga M, Torres N, Garcia-Perdomo H.
    An Bras Dermatol; 2018 Jan; 93(5):686-695. PubMed ID: 30156618
    [Abstract] [Full Text] [Related]

  • 4. Oral erythromycin is ineffective in the treatment of pityriasis rosea.
    Rasi A, Tajziehchi L, Savabi-Nasab S.
    J Drugs Dermatol; 2008 Jan; 7(1):35-8. PubMed ID: 18246696
    [Abstract] [Full Text] [Related]

  • 5. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial.
    Singh S, Anurag, Tiwary NK.
    Indian J Dermatol Venereol Leprol; 2016 Jan; 82(5):505-9. PubMed ID: 27212277
    [Abstract] [Full Text] [Related]

  • 6. Oral erythromycin is ineffective in the treatment of pityriasis rosea.
    Bukhari IA.
    J Drugs Dermatol; 2008 Jul; 7(7):625. PubMed ID: 18664152
    [No Abstract] [Full Text] [Related]

  • 7. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial.
    Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana L.
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):241-4. PubMed ID: 10642679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A position statement on the management of patients with pityriasis rosea.
    Chuh A, Zawar V, Sciallis G, Kempf W.
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1670-1681. PubMed ID: 27406919
    [Abstract] [Full Text] [Related]

  • 10. Interventions for pityriasis rosea.
    Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, Garner SE, Chu F.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD005068. PubMed ID: 17443568
    [Abstract] [Full Text] [Related]

  • 11. The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.
    Ehsani A, Esmaily N, Noormohammadpour P, Toosi S, Hosseinpour A, Hosseini M, Sayanjali S.
    Indian J Dermatol; 2010 Apr 18; 55(3):246-8. PubMed ID: 21063515
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antivirals for pityriasis rosae.
    Castanedo-Cazares JP, Lepe V, Moncada B.
    Photodermatol Photoimmunol Photomed; 2004 Apr 18; 20(2):110. PubMed ID: 15030598
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea.
    Ganguly S.
    J Clin Diagn Res; 2014 May 18; 8(5):YC01-4. PubMed ID: 24995231
    [Abstract] [Full Text] [Related]

  • 18. Paraviral exanthems.
    Fölster-Holst R, Zawar VP, Chuh A.
    Expert Rev Anti Infect Ther; 2016 Jun 18; 14(6):601-11. PubMed ID: 27144956
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.